Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Dermatol. 2011 Dec;23(Suppl 3):S329-32. doi: 10.5021/ad.2011.23.S3.S329. Epub 2011 Dec 27.

Fexofenadine-induced urticaria.

Author information

  • 1Department of Dermatology, School of Medicine, Ewha Womans University, Seoul, Korea.

Abstract

Fexofenadine (Allegra® 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.

KEYWORDS:

Basophil degranulation test; Drug eruotion/etiology; Fexofenadine; Histamine H1 antagonist/adverse effects

PMID:
22346270
[PubMed]
PMCID:
PMC3276789
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Korean Dermatological Association Icon for PubMed Central
    Loading ...
    Write to the Help Desk